Updated May 2026
Rybelsus vs Saxenda
Side-by-side comparison of Rybelsus (semaglutide (oral)) and Saxenda (liraglutide (daily injection)) across efficacy, food restrictions, monthly cost, and Medicare Bridge coverage.
Our pick for most patients
Rybelsus
Based on the data below, Rybelsus wins on lower cash price ($998/mo vs $1349/mo). Your situation may differ — try the personalized matcher on the homepage or compute your real out-of-pocket with the cost calculator on each medication's detail page.
| Field | Rybelsus | Saxenda |
|---|---|---|
| Route | tablet · daily | injection · daily |
| Avg weight loss | 8–10% | 5–8% |
| Food restriction | 30-min fast required | No food restriction |
| Cash from | $998/mo | $1349/mo |
| Savings card | — | — |
| Medicare Bridge | Tier 4 | Tier 4 |
| A1c reduction | −1.4% | — |
| FDA approved | 2019-09 | 2014-12 |
- RouteRybelsustablet · dailySaxendainjection · daily
- Avg weight lossRybelsus8–10%Saxenda5–8%
- Food restrictionRybelsus30-min fast requiredSaxendaNo food restriction
- Cash fromRybelsus$998/moSaxenda$1349/mo
- Savings cardRybelsus—Saxenda—
- Medicare BridgeRybelsusTier 4SaxendaTier 4
- A1c reductionRybelsus−1.4%Saxenda—
- FDA approvedRybelsus2019-09Saxenda2014-12
Pick Rybelsus if…
- Cash pay matters more than peak weight loss ($998/mo cheaper)
- You're needle-averse
- You want the higher peak efficacy (10% vs 8%)
Pick Saxenda if…
- You can't reliably do a fasting window before meds
Not sure which fits?
The 30-second matcher on the homepage scores every 2026 GLP-1 against your goals + preferences and recommends the best fit.